Visit https://www.peervoice.com/ABV860 to view the entire programme with slides. After completing “"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.